Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness
C Pelaia, C Calabrese, R Terracciano… - Therapeutic …, 2018 - journals.sagepub.com
Omalizumab was the first, and for a long time the only available monoclonal antibody for the
add-on treatment of severe allergic asthma. In particular, omalizumab selectively targets …
add-on treatment of severe allergic asthma. In particular, omalizumab selectively targets …
[PDF][PDF] Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness
C Pelaia, C Calabrese, R Terracciano, F de Blasio… - 2018 - scholar.archive.org
Omalizumab was the first, and for a long time the only available monoclonal antibody for the
add-on treatment of severe allergic asthma. In particular, omalizumab selectively targets …
add-on treatment of severe allergic asthma. In particular, omalizumab selectively targets …
[PDF][PDF] Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness
C Pelaia, C Calabrese, R Terracciano, F de Blasio… - 2018 - academia.edu
Omalizumab was the first, and for a long time the only available monoclonal antibody for the
add-on treatment of severe allergic asthma. In particular, omalizumab selectively targets …
add-on treatment of severe allergic asthma. In particular, omalizumab selectively targets …
[引用][C] Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness
C Pelaia, C Calabrese, R Terracciano… - THERAPEUTIC …, 2018 - iris.unicz.it
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a
decade of real-life effectiveness IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore …
decade of real-life effectiveness IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore …
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness
C Pelaia, C Calabrese, R Terracciano… - THERAPEUTIC …, 2018 - iris.unicampania.it
Omalizumab was the first, and for a long time the only available monoclonal antibody for the
add-on treatment of severe allergic asthma. In particular, omalizumab selectively targets …
add-on treatment of severe allergic asthma. In particular, omalizumab selectively targets …
[HTML][HTML] Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness
C Pelaia, C Calabrese, R Terracciano… - Therapeutic …, 2018 - ncbi.nlm.nih.gov
Omalizumab was the first, and for a long time the only available monoclonal antibody for the
add-on treatment of severe allergic asthma. In particular, omalizumab selectively targets …
add-on treatment of severe allergic asthma. In particular, omalizumab selectively targets …
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness
C Pelaia, C Calabrese… - Therapeutic …, 2018 - pubmed.ncbi.nlm.nih.gov
Omalizumab was the first, and for a long time the only available monoclonal antibody for the
add-on treatment of severe allergic asthma. In particular, omalizumab selectively targets …
add-on treatment of severe allergic asthma. In particular, omalizumab selectively targets …
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness.
C Pelaia, C Calabrese, R Terracciano… - Therapeutic …, 2018 - europepmc.org
Omalizumab was the first, and for a long time the only available monoclonal antibody for the
add-on treatment of severe allergic asthma. In particular, omalizumab selectively targets …
add-on treatment of severe allergic asthma. In particular, omalizumab selectively targets …
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness
C Pelaia, C Calabrese, R Terracciano… - THERAPEUTIC …, 2018 - iris.unisa.it
Omalizumab was the first, and for a long time the only available monoclonal antibody for the
add-on treatment of severe allergic asthma. In particular, omalizumab selectively targets …
add-on treatment of severe allergic asthma. In particular, omalizumab selectively targets …
[PDF][PDF] Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness
C Pelaia, C Calabrese, R Terracciano, F de Blasio… - 2018 - researchgate.net
Omalizumab was the first, and for a long time the only available monoclonal antibody for the
add-on treatment of severe allergic asthma. In particular, omalizumab selectively targets …
add-on treatment of severe allergic asthma. In particular, omalizumab selectively targets …